↓ Skip to main content

Viral Hepatitis and Liver Disease

Overview of attention for book
Cover of 'Viral Hepatitis and Liver Disease'

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 1 What a Dumb Way to Designate Germs
  3. Altmetric Badge
    Chapter 2 Recollections of a Hepatitis Investigator—1940–1993
  4. Altmetric Badge
    Chapter 3 The Hepatitis Viruses: Accomplishments and Problems
  5. Altmetric Badge
    Chapter 4 How Far Have We Come, and Where Are We Going? 3 Years After 1990
  6. Altmetric Badge
    Chapter 5 How Far Have We Come and Where Are We Going? Pathogen-oriented Prevention of Hepatocellular Carcinoma in Japan in 1993
  7. Altmetric Badge
    Chapter 6 The Hepatitis Viruses: An Overview
  8. Altmetric Badge
    Chapter 7 Recent Advances in Understanding the Molecular Virology of Hepatoviruses: Contrasts and Comparisons with Hepatitis C Virus
  9. Altmetric Badge
    Chapter 8 Hepatocarcinogenic Mechanisms in Hepadnavirus-infected Hosts
  10. Altmetric Badge
    Chapter 9 The Hepatitis C Virus: Genetic Organization, Persistence, and Vaccine Strategies
  11. Altmetric Badge
    Chapter 10 The Molecular Biology of Hepatitis Delta Virus: Recent Advances
  12. Altmetric Badge
    Chapter 11 Molecular and Serological Characteristics of Hepatitis E Virus
  13. Altmetric Badge
    Chapter 12 Classification and Taxonomy of Hepatitis Viruses: Summary of a Workshop
  14. Altmetric Badge
    Chapter 13 Taxonomic Classification of Hepatitis A Virus
  15. Altmetric Badge
    Chapter 14 Classification and Taxonomy of the Hepadnaviruses—Current Status
  16. Altmetric Badge
    Chapter 15 Viral Hepatitis and Liver Disease
  17. Altmetric Badge
    Chapter 16 The Taxonomy of Hepatitis Delta Virus
  18. Altmetric Badge
    Chapter 17 Hepatitis E Virus: Some Characteristics Relevant to Virus Classification
  19. Altmetric Badge
    Chapter 18 New Agent(s) to Cause Hepatitis?: Summary of a Specialty Session
  20. Altmetric Badge
    Chapter 19 Candidate Hepatitis F Virus in Sporadic Non-A, Non-B Acute Liver Failure: Exclusion in Liver of Hepatitis Viruses A, E, C and B by Polymerase Chain Reaction
  21. Altmetric Badge
    Chapter 20 Non-A, Non-B, Non-C, Non-E Acute Hepatitis: Does it Really Exist?
  22. Altmetric Badge
    Chapter 21 Clinical and Laboratory Features of Acute Community-acquired Non-A, Non-B, Non-C Hepatitis
  23. Altmetric Badge
    Chapter 22 Chronic Non-A, Non-B, Non-C Hepatitis in French Blood Donors Assessed with HCV Third-generation Tests and Polymerase Chain Reaction
  24. Altmetric Badge
    Chapter 23 Evidence for Parenterally Transmitted non-A, non-B, non-C, non-D, non-E Hepatitis in Russia
  25. Altmetric Badge
    Chapter 24 Molecular Biology of Hepatitis B Virus
  26. Altmetric Badge
    Chapter 25 Expression of Defective Hepatitis B (HBV)-DNA, Synthesized from a Singly Spliced HBV-RNA, Leads to Cytoplasmic Accumulation of Capsid and X Proteins
  27. Altmetric Badge
    Chapter 26 Methods for the Purification of Enzymatically Active Reverse Transcriptase of Duck Hepatitis B Virus
  28. Altmetric Badge
    Chapter 27 Some Aspects of Hepatitis C Virus: A Review and a Hypothesis
  29. Altmetric Badge
    Chapter 28 In Vivo and In Vitro Replication, Expression, Processing, and Assembly of Hepatitis C Virus: Summary of a Speciality Session
  30. Altmetric Badge
    Chapter 29 Molecular Biology of Pestiviruses and Comparison with HCV
  31. Altmetric Badge
    Chapter 30 Virus-like Particles in the Liver of an Owl Monkey Inoculated with Hepatitis C Virus
  32. Altmetric Badge
    Chapter 31 Useful Markers for Predicting in Vivo Infectivity of Hepatitis C Virus
  33. Altmetric Badge
    Chapter 32 HCV-specific Translation Initiation
  34. Altmetric Badge
    Chapter 33 Translation Initiation Mechanism on Hepatitis C Virus RNA
  35. Altmetric Badge
    Chapter 34 Mapping of the Internal Ribosome Entry Site at the 5′ End of the Hepatitis C Virus Genome
  36. Altmetric Badge
    Chapter 35 Secondary Structure and Protein-binding Activities of the 5′ Nontranslated Region of the Hepatitis C Virus Genome
  37. Altmetric Badge
    Chapter 36 Hepatitis C Virus Polyprotein Processing
  38. Altmetric Badge
    Chapter 37 Processing Mechanisms of Nonstructural Proteins of Hepatitis C Virus
  39. Altmetric Badge
    Chapter 38 Immunoelectron Microscopic Localization of Processed Core Protein of Hepatitis C Virus in COS Cells
  40. Altmetric Badge
    Chapter 39 The Physical State of the Negative Strand of Hepatitis C Virus RNA in Serum
  41. Altmetric Badge
    Chapter 40 Cellular Immune Responses to Hepatitis Viruses: Summary of a Specialty Session
  42. Altmetric Badge
    Chapter 41 Studies of Cytotoxic T Lymphocyte Activity in Tamarins with Acute Hepatitis A Virus Infection
  43. Altmetric Badge
    Chapter 42 Adoptive Transfer of Immunity to Hepatitis B Through Bone Marrow Transplantation from Immunized Donors
  44. Altmetric Badge
    Chapter 43 Peptide Recognition and Competition, T Cell Receptor Usage, and HLA Restriction Elements of T Cell Clones Specific to a Determinant of Hepatitis B Virus Core and e Antigens in Chronic Type B Hepatitis
  45. Altmetric Badge
    Chapter 44 A Method to Detect Hepatitis B Virus-specific Cytotoxic T Lymphocytes in Patients with Acute and Chronic HBV Infection
  46. Altmetric Badge
    Chapter 45 The Role of the Cytotoxic T Lymphocyte Response in Hepatitis B Virus Immunobiology and Pathogenesis
  47. Altmetric Badge
    Chapter 46 Variable Region Usage in T Lymphocytes Infiltrating Liver Tissues of Chronic Liver Diseases
  48. Altmetric Badge
    Chapter 47 In Vitro Immune Responses Specific for NS3 Regional Peptide (C7) and Core Regional Peptide (C11) of HCV in Chronic Hepatitis C
  49. Altmetric Badge
    Chapter 48 Recognition of Hepatitis C Virus Nucleocapsid Protein-derived Peptides by Cytotoxic T Lymphocytes
  50. Altmetric Badge
    Chapter 49 Hepatitis C Virus-specific Cytotoxic T Lymphocytes Restricted by HLA-A2 are Present in the Peripheral Blood of Patients with Chronic Hepatitis C
  51. Altmetric Badge
    Chapter 50 In Vitro Studies on the Effects of Hepatitis C Virus on Hemopoiesis
  52. Altmetric Badge
    Chapter 51 Pathobiology of Fulminant Hepatitis
  53. Altmetric Badge
    Chapter 52 Autoimmune Hepatitis
  54. Altmetric Badge
    Chapter 53 HCV in Autoimmune and Extrahepatic Syndromes: Synopsis of a Speciality Session
  55. Altmetric Badge
    Chapter 54 Mechanisms Involved in the Pathogenesis of Cryoglobulinemia in Patients with Chronic Hepatitis C and Other Causes of Chronic Liver Diseases
  56. Altmetric Badge
    Chapter 55 Clinical, Immunological, and Virological Features of HCV-associated Membranoproliferative Glomerulonephritis
  57. Altmetric Badge
    Chapter 56 Is Hepatitis C Virus Infection a Trigger of Porphyria Cutanea Tarda?
  58. Altmetric Badge
    Chapter 57 Contribution of Hepatitis C Virus Infection to the Development of Sjögren’s Syndrome in Japan
  59. Altmetric Badge
    Chapter 58 Reactivity of Sera from Japanese Patients with Type 2 Autoimmune Hepatitis to Peptides Derived from Host Genes, Cytochrome HLD8-2 and GOR
  60. Altmetric Badge
    Chapter 59 The Meanings of Mutations in and Around Pre-C/C and Pre-S/S Regions of HBV: Summary of a Specialty Session
  61. Altmetric Badge
    Chapter 60 Genetic and Biological Characterization of Two Hepatitis B Virus Variants: A Precore Mutant Implicated in Fulminant Hepatitis and a Surface Mutant Resistant to Immunoprophylaxis
  62. Altmetric Badge
    Chapter 61 Vaccine-associated Mutants of Hepatitis B Virus
  63. Altmetric Badge
    Chapter 62 A Novel Antibody Escape Variant (Ala 144) of Hepatitis B Virus in an Identical Twin Before Selection in the Mother
  64. Altmetric Badge
    Chapter 63 Hepatitis B Virus Variants with Altered a Determinants Causing Infections in Immunized Children
  65. Altmetric Badge
    Chapter 64 Hepatitis B Virus Precore Mutants
  66. Altmetric Badge
    Chapter 65 Wild-type and HBeAg-minus HBV Fluctuations: Cause or Effect of Chronic Hepatitis B Pathogenic Mechanisms?
  67. Altmetric Badge
    Chapter 66 Nucleotide Sequence Analysis of the Precore Region in Patients with Fulminant Hepatitis B in the USA
  68. Altmetric Badge
    Chapter 67 Base Pairing in the Pregenome Encapsidation Signal of HBV: A Clue for the Prevalence of Naturally Occurring HBeAg-minus Precore Mutations
  69. Altmetric Badge
    Chapter 68 Core Protein Evolution After Selection of Hepatitis B Precore Mutants and Correlation with Disease Severity
  70. Altmetric Badge
    Chapter 69 Mutations in the Core Nucleotide Sequence of Hepatitis B Virus Correlate with Severe Liver Damage
  71. Altmetric Badge
    Chapter 70 Diversity of the Classification and Nomenclature Systems for Hepatitis C Virus Genotypes: A Proposed Solution to the Present Confusion
  72. Altmetric Badge
    Chapter 71 The Molecular Diversity of Hepatitis C Virus and Its Clinical Significance: Summary of a Satellite Symposium
  73. Altmetric Badge
    Chapter 72 Molecular Evolutionary Classification of Hepatitis C Viruses and their Divergence Times
  74. Altmetric Badge
    Chapter 73 Sequence Analysis of the 5′ Noncoding Region Reveals the Existence of Multiple Hepatitis C Virus Genotypes in Quebec, Canada
  75. Altmetric Badge
    Chapter 74 Hepatitis C Virus Genotypes: An Investigation of Type-specific Differences in Geographic Origin and Disease
  76. Altmetric Badge
    Chapter 75 A Distinct Genetic Group of Hepatitis C Virus Circulating Within the Former Soviet Union
  77. Altmetric Badge
    Chapter 76 Sequence Analysis of Hepatitis C Virus Obtained from Indonesian Patients and Identification of Novel Sequence Variants
  78. Altmetric Badge
    Chapter 77 Low Prevalence of Anti-E1 Antibodies Reactive to Recombinant Type 1b E1 Envelope Protein in Type 2, 3, and 4 HCV Sera, but High Prevalence in Subtypes 1a and 1b
  79. Altmetric Badge
    Chapter 78 The Use of a Line Probe Assay as a Tool to Detect New Types or Subtypes of the Hepatitis C Virus
  80. Altmetric Badge
    Chapter 79 Distinct Subtypes of Hepatitis C Virus Defined by Antibodies Directed to the Putative Core, NS4, and NS5 Region Polypeptides
  81. Altmetric Badge
    Chapter 80 Sequencing and Genotyping of Hepatitis C Virus in Patients with Autoimmune Hepatitis Type 2
  82. Altmetric Badge
    Chapter 81 Hepatitis C Virus Hypervariable Region May Confer Escape from Immunosurveillance
  83. Altmetric Badge
    Chapter 82 New Methods for HCV Diagnosis: Summary of a Specialty Session
  84. Altmetric Badge
    Chapter 83 Current and Future Status of Hepatitis C Virus Diagnosis: Summary of a Satellite Symposium
  85. Altmetric Badge
    Chapter 84 Antibody Profile of Blood Donors Infected with Hepatitis C Virus
  86. Altmetric Badge
    Chapter 85 Recombinant Proteins and Synthetic Peptides Containing Antigenic Epitopes of the Hepatitis C Virus Proteins and Development of a New Diagnostic Test Format
  87. Altmetric Badge
    Chapter 86 Earlier Detection of anti-HCV Seroconversion in Post-Transfusion NANBH by a Prototype HCV 3.0 ELISA
  88. Altmetric Badge
    Chapter 87 Blood Screening for Asymptomatic Hepatitis C Virus Carriers with Second-generation Hepatitis C Virus Antibody Assays
  89. Altmetric Badge
    Chapter 88 An Automated Diagnostic Assay for HCV
  90. Altmetric Badge
    Chapter 89 Replicative Level of HCV Determined by the Competitive Reverse Transcription and Polymerase Chain Reaction Assay in Various Stages of Chronic HCV Infection
  91. Altmetric Badge
    Chapter 90 Three-band Nested Double PCR for Semiquantitation of Hepatitis C Virus in Donated Blood: Comparison with Antibody and Alanine Aminotransferase Level
  92. Altmetric Badge
    Chapter 91 Diagnosis and Epidemiology of HEV: Summary of a Specialty Session
  93. Altmetric Badge
    Chapter 92 Assay Development of Diagnostic Tests for Hepatitis E
  94. Altmetric Badge
    Chapter 93 Recombinant Antigens and Synthetic Peptides for Serodiagnosis of Hepatitis E Virus Infection
  95. Altmetric Badge
    Chapter 94 Hepatitis E Among Refugees in Kenya: Minimal Apparent Person-to-person Transmission, Evidence for Age-dependent Disease Expression, and New Serologic Assays
  96. Altmetric Badge
    Chapter 95 Viral Hepatitis in Africa in the 90s: Facing Realities
  97. Altmetric Badge
    Chapter 96 Viral Hepatitis in Asia: Summary of a Plenary Session
  98. Altmetric Badge
    Chapter 97 Hepatitis in the South Pacific
  99. Altmetric Badge
    Chapter 98 Global Perspective of Viral Hepatitis and Liver Disease: The Western Pacific
  100. Altmetric Badge
    Chapter 99 Hepatitis in Indonesia
  101. Altmetric Badge
    Chapter 100 Viral Hepatitis in India
  102. Altmetric Badge
    Chapter 101 Viral Hepatitis in the Philippines: a Perspective
  103. Altmetric Badge
    Chapter 102 Perspective of Viral Hepatitis in Thailand
  104. Altmetric Badge
    Chapter 103 Etiology of Chronic Liver Disease in Nepal
  105. Altmetric Badge
    Chapter 104 Epidemiology of Hepatitis E Virus (HEV): A Cohort Study in Kathmandu, Nepal
  106. Altmetric Badge
    Chapter 105 Epidemiology of Hepatitis B and C in China
  107. Altmetric Badge
    Chapter 106 Prevalence of Hepatitis C Virus Infection in Nanjing, Southern China
  108. Altmetric Badge
    Chapter 107 Viral Hepatitis in Taiwan: Status in the 1990s
  109. Altmetric Badge
    Chapter 108 Relative Etiologic Role of Hepatitis B Virus and Hepatitis C Virus in Chronic Liver Diseases Among Age-specific Groups in Korea
  110. Altmetric Badge
    Chapter 109 Viral Hepatitis in Japan
  111. Altmetric Badge
    Chapter 110 Viral Hepatitis in the Former Soviet Union
  112. Altmetric Badge
    Chapter 111 A Seroprevalence Study of Hepatitis E in Europe and the Middle East
  113. Altmetric Badge
    Chapter 112 Perspectives on Viral Hepatitis Elimination in Europe
  114. Altmetric Badge
    Chapter 113 Viral Hepatitis in North America
  115. Altmetric Badge
    Chapter 114 Transmission Patterns in Hepatitis C Virus Infection
  116. Altmetric Badge
    Chapter 115 Hepatitis C Virus Infections in U.S. Families
  117. Altmetric Badge
    Chapter 116 Sexual Transmission of Hepatitis C Virus
  118. Altmetric Badge
    Chapter 117 Transmission of Hepatitis C Virus Through Needlestick Accidents in Health Care Workers
  119. Altmetric Badge
    Chapter 118 HCV-positive, HIV-1-negative Mothers Transmit HCV
  120. Altmetric Badge
    Chapter 119 Prospective Study of Mother-to-infant Transmission of Hepatitis C Virus
  121. Altmetric Badge
    Chapter 120 Serial Follow-up of Hepatitis C Virus RNA and Antibody in Infants Born to Hepatitis C Virus Positive but Human Immunodeficiency Virus Negative Mothers
  122. Altmetric Badge
    Chapter 121 Mother-to-Infant Transmission of Hepatitis C Virus—A Prospective Study
  123. Altmetric Badge
    Chapter 122 Hepatitis C Virus Infection in Health Care Workers
  124. Altmetric Badge
    Chapter 123 Evidence of HCV Infection by Means of RIBA in a Population of Drug Abusers
  125. Altmetric Badge
    Chapter 124 Serological Response to Hepatitis C Virus (HCV) in Serial Bleeds from Hemodialysis Patients
  126. Altmetric Badge
    Chapter 125 Hepatitis C Virus RNA in Anti-HCV-positive Hemodialyzed Patients: Significance and Therapeutic Implications
  127. Altmetric Badge
    Chapter 126 Hepatitis C After Kidney Transplantation
  128. Altmetric Badge
    Chapter 127 Prevention
  129. Altmetric Badge
    Chapter 128 Strategies for the Development of Hepatitis C and E Vaccine: Summary of a Breakfast Workshop
  130. Altmetric Badge
    Chapter 129 New Hepatitis A and B Vaccines: Summary of a Specialty Session
  131. Altmetric Badge
    Chapter 130 A New Vaccine for the Prevention of Hepatitis A: Summary of a Satellite Symposium
  132. Altmetric Badge
    Chapter 131 Toward Zero Occurrence of Post-transfusion Hepatitis: Summary of a Specialty Session
  133. Altmetric Badge
    Chapter 132 Hepatitis A Vaccine Development in Japan
  134. Altmetric Badge
    Chapter 133 Reactogenicity and Immunogenicity of a Combined Hepatitis A and B Vaccine in Healthy Adults
  135. Altmetric Badge
    Chapter 134 Prevention of Hepatitis B Infection
  136. Altmetric Badge
    Chapter 135 Prevention of Hepatitis B in Asia
  137. Altmetric Badge
    Chapter 136 Implementation of Hepatitis B Virus Vaccination in Latin America: Current and Future Perspective of a Global Action
  138. Altmetric Badge
    Chapter 137 The Immunogenicity and Reactogenicity of Combined Tetravalent Diphtheria, Tetanus, Pertussis, and Hepatitis B Vaccine in Infants
  139. Altmetric Badge
    Chapter 138 Vertical Transmission of Hepatitis B Virus and its Prevention in Japan
  140. Altmetric Badge
    Chapter 139 Clinical Trial of a PreS2-containing Recombinant Hepatitis B Vaccine
  141. Altmetric Badge
    Chapter 140 The Use of a PreS2-containing Recombinant Vaccine for the Prevention of Maternal Transmission of Hepatitis B Virus in Indonesian Neonates
  142. Altmetric Badge
    Chapter 141 Clinical Experience with the PreS1-containing Hepatitis B Vaccine (HG-3) in Different Nonresponder Groups
  143. Altmetric Badge
    Chapter 142 Immunogenicity of a Mammalian Cell-derived Recombinant Hepatitis B Vaccine Containing Pre S2 and Pre S1 Antigens: A Preliminary Report
  144. Altmetric Badge
    Chapter 143 Vaccination of Hepatitis E Virus
  145. Altmetric Badge
    Chapter 144 Posttransfusion Hepatitis in the United States
  146. Altmetric Badge
    Chapter 145 Prevention of Post-transfusion Hepatitis in Japan
  147. Altmetric Badge
    Chapter 146 Transfusion-associated Hepatitis (TAH) in Polytransfused Thalassemic Children Following the Introduction of Anti-HCV Donor Screening in Sardinia
  148. Altmetric Badge
    Chapter 147 Effect of Donor Blood Screening for Anti-HCV Antibody by the Second-generation Passive Hemagglutination Test on the Incidence of Post-Transfusion Hepatitis
  149. Altmetric Badge
    Chapter 148 Hepatitis C Viremia and Serologic Profile in Post-Transfusion Non-A, Non-B Hepatitis
  150. Altmetric Badge
    Chapter 149 Presence of Detectable HCV-RNA in the Absence of Positive HCV Serology in Blood Donors Infected with HTLV-I/II
  151. Altmetric Badge
    Chapter 150 Detection and Quantitation of HCV-RNA in Immune Globulins Produced by Cohn-Oncley Fractionation of Human Plasma
  152. Altmetric Badge
    Chapter 151 Immunoglobulin Safety Related to Testing for Antibody to Hepatitis C Virus
  153. Altmetric Badge
    Chapter 152 Cytokines in the Treatment of Human Diseases: Introduction and Summary of a Plenary Session
  154. Altmetric Badge
    Chapter 153 Cytokines in the Treatment of Human Disease: The Interferon System—from the Laboratory to the Clinic
  155. Altmetric Badge
    Chapter 154 Basic Research and Clinical Applications of Natural Interferon-β:Summary of a Satellite Symposium
  156. Altmetric Badge
    Chapter 155 Treatment of Hepatitis C with Interferon: Mechanism of Action of Interferon
  157. Altmetric Badge
    Chapter 156 A Randomized, Controlled Trial of Interferon-β Treatment for Acute Hepatitis C
  158. Altmetric Badge
    Chapter 157 Outcome of Acute Hepatitis C and Role of Alpha Interferon Therapy
  159. Altmetric Badge
    Chapter 158 Treatment of Chronic Hepatitis C with Interferon-α
  160. Altmetric Badge
    Chapter 159 Changes in Levels of HCV-RNA and Hepatitis C Viral Antigen Associated with Interferon-alpha Therapy of Chronic Hepatitis C
  161. Altmetric Badge
    Chapter 160 Predictors of Alpha Interferon Response in Patients with Chronic Hepatitis C
  162. Altmetric Badge
    Chapter 161 High Virus Titer, Slow Virus Decrease, Genotype II, and Sequence Variability of E2/NS1 HVR Predict Poor Response to Interferon Therapy in Chronic Hepatitis C
  163. Altmetric Badge
    Chapter 162 More Reasons for Hope in the Therapy of Chronic Hepatitis C
  164. Altmetric Badge
    Chapter 163 Breakthrough in Chronic Hepatitis C During Recombinant Alpha Interferon Therapy
  165. Altmetric Badge
    Chapter 164 Hepatitis C Viral RNA and Hepatic Cytokine Expression in Chronic Hepatitis C: Effects of Alpha Interferon Therapy
  166. Altmetric Badge
    Chapter 165 Relationship Between Serum 2-5AS Activity and the Reduction of HCV-RNA During Interferon Therapy
  167. Altmetric Badge
    Chapter 166 Long-term Histologic Improvement and Persistent HCV Replication in Patients with Chronic Hepatitis C Having Responded to Recombinant Alpha Interferon
  168. Altmetric Badge
    Chapter 167 Interferon Therapy in Chronic Hepatitis C and Liver Histology
  169. Altmetric Badge
    Chapter 168 Ribavirin or Alpha Interferon Treatment of Chronic Hepatitis C: Assessment of Antiviral Efficacy
  170. Altmetric Badge
    Chapter 169 Non-interferon Treatment of Viral Hepatitis: Addendum to a Summary of a Breakfast Workshop
  171. Altmetric Badge
    Chapter 170 Effect of the Polysaccharide Sizofiran, an Immunotherapeutic Agent, on HBeAg-positive Chronic Hepatitis
  172. Altmetric Badge
    Chapter 171 Clinical Effect of an Immunostimulant Agent, Propagermanium, in Chronic Hepatitis B
  173. Altmetric Badge
    Chapter 172 Experience in Germany with Glycyrrhizinic Acid for the Treatment of Chronic Viral Hepatitis
  174. Altmetric Badge
    Chapter 173 Therapeutic Approach to the Chronic Active Liver Disease: Summary of a Satellite Symposium
  175. Altmetric Badge
    Chapter 174 Current Issues in Hepatocellular Carcinoma: Hepatitis B Virus, Hepatitis C Virus, and the p53 Tumor Suppressor Gene —Summary of Plenary Session 5—
  176. Altmetric Badge
    Chapter 175 Viral Hepatocarcinogenesis: Addendum to a Summary of a Breakfast Workshop
  177. Altmetric Badge
    Chapter 176 Type C Hepatitis and Hepatocellular Carcinoma: Summary of a Specialty Session
  178. Altmetric Badge
    Chapter 177 Virus and Host Genes in HCC: Summary of a Specialty Session
  179. Altmetric Badge
    Chapter 178 Chemoprevention of Hepatocellular Carcinoma: Summary of a Satellite Symposium
  180. Altmetric Badge
    Chapter 179 Epidemiology of Hepatocellular Carcinoma
  181. Altmetric Badge
    Chapter 180 Hepatitis B and C Virus Infections in Hepatocellular Carcinoma and Their Prevention
  182. Altmetric Badge
    Chapter 181 Chronological Changes of Hepatitis B and C Virus Markers in Japanese Patients with Hepatocellular Carcinoma
  183. Altmetric Badge
    Chapter 182 Hepatitis B and C in Patients with Hepatocellular Carcinoma in Brazil
  184. Altmetric Badge
    Chapter 183 Association Between Hepatitis B and C Virus Infection and Chinese Hepatocellular Carcinoma: A Case-Control Study
  185. Altmetric Badge
    Chapter 184 A Study of the Prevalence of Anti-HCV in Hepatocellular Carcinoma Associated with Cirrhosis
  186. Altmetric Badge
    Chapter 185 Antibody Pattern of HCV Infection and Hepatocellular Carcinoma in Italy: A Case Control Study
  187. Altmetric Badge
    Chapter 186 Hepatitis C Virus Infection and Replication in Patients with Hepatocellular Carcinoma
  188. Altmetric Badge
    Chapter 187 Close Correlation Between the Rate of Mortality Due to Hepatocellular Carcinoma and the Carrier Rate of HCV, Especially HCV Genotype II (or 1b)
  189. Altmetric Badge
    Chapter 188 Type C Hepatitis and Hepatocellular Carcinoma in Japan
  190. Altmetric Badge
    Chapter 189 Mechanisms of Activation of Cellular Gene Expression by Integrated HBV-DNA
  191. Altmetric Badge
    Chapter 190 The Role of Integrated Hepadnavirus Sequences in Hepatocellular Carcinoma
  192. Altmetric Badge
    Chapter 191 Analysis of HBV Integration Sites in Liver Tumors Without Accompanying Cirrhosis
  193. Altmetric Badge
    Chapter 192 Integrated Viral Sequences may Contribute in cis and in trans to Hepatocarcinogenesis in Woodchuck Hepatitis Virus-infected Woodchucks
  194. Altmetric Badge
    Chapter 193 Mitogenic Activity of Hepatitis B Virus HBx Gene in Vivo and in Vitro
  195. Altmetric Badge
    Chapter 194 Dual Control of Human Hepatitis B Virus X Protein
  196. Altmetric Badge
    Chapter 195 The AP1 Transcription Factor as a Model to Study the Modulation of Intracellular Signalling Pathways by the Hepatitis B Virus Transactivator pX
  197. Altmetric Badge
    Chapter 196 Contribution of HBV X Gene Expression to Hepatic Carcinogenesis
  198. Altmetric Badge
    Chapter 197 Rate of Persistence, Structure, and Expression of HBV Genome in HCC Developing in HBsAg-negative Patients
  199. Altmetric Badge
    Chapter 198 Loss of Tumor Suppressor Genes in HCC in Japan and Australia
  200. Altmetric Badge
    Chapter 199 Duck Hepatocellular Carcinoma from a High Incidence Area: Analysis for Duck Hepatitis B Virus Infection and p53 Mutation
  201. Altmetric Badge
    Chapter 200 Image Diagnosis of Hepatocellular Carcinoma
  202. Altmetric Badge
    Chapter 201 Noninvasive Treatment for Hepatocellular Carcinoma
  203. Altmetric Badge
    Chapter 202 Where Are We Going?—Toward Continued Victory over Viruses
  204. Altmetric Badge
    Chapter 203 From Here to 1996
  205. Altmetric Badge
    Chapter 204 Jazz and All That HCV: From Molecules to More Cures
  206. Altmetric Badge
    Chapter 205 Something Perhaps Unique to the 1993 ISVHLD: Statistics and Acknowledgments
Overall attention for this book and its chapters
Altmetric Badge

Citations

dimensions_citation
39 Dimensions

Readers on

mendeley
6 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Viral Hepatitis and Liver Disease
Published by
Springer, Tokyo, January 1994
DOI 10.1007/978-4-431-68255-4
ISBNs
978-4-43-168257-8, 978-4-43-168255-4
Editors

K. Nishioka, H. Suzuki, S. Mishiro, T. Oda

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 6 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 6 100%

Demographic breakdown

Readers by professional status Count As %
Professor > Associate Professor 2 33%
Student > Bachelor 1 17%
Student > Master 1 17%
Unknown 2 33%
Readers by discipline Count As %
Environmental Science 1 17%
Agricultural and Biological Sciences 1 17%
Medicine and Dentistry 1 17%
Unknown 3 50%